We are live on ! Find out more
ACS

Archford Capital Strategies Portfolio holdings

AUM $987M
1-Year Est. Return 29.31%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+29.31%
3 Year Est. Return
+76.21%
5 Year Est. Return
+80.45%
10 Year Est. Return
+551.54%
AUM
$136M
AUM Growth
+$10.2M
Cap. Flow
+$3.77M
Cap. Flow %
2.78%
Top 10 Hldgs %
30.52%
Holding
821
New
42
Increased
153
Reduced
89
Closed
40

Top Sells

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$809K
2
GD icon
General Dynamics
GD
+$734K
3
MCD icon
McDonald's
MCD
+$700K
4
DGX icon
Quest Diagnostics
DGX
+$676K
5
TROW icon
T. Rowe Price
TROW
+$612K

Sector Composition

Rank Sector Weight
1 Industrials 16.97%
2 Technology 7.56%
3 Healthcare 5.69%
4 Consumer Staples 5.02%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYGN icon
551
Myriad Genetics
MYGN
$312M
$1K ﹤0.01%
15
NGVC icon
552
Vitamin Cottage Natural Grocers
NGVC
$649M
$1K ﹤0.01%
45
NVO
553
Novo Nordisk
NVO
$203B
$1K ﹤0.01%
46
-14
-23% -$313
OGE icon
554
OGE Energy
OGE
$9.69B
$1K ﹤0.01%
16
OI icon
555
O-I Glass
OI
$1.06B
$1K ﹤0.01%
19
OII icon
556
Oceaneering
OII
$5.14B
$1K ﹤0.01%
12
ACH
557
Accendra Health
ACH
$83.8M
$1K ﹤0.01%
18
PH icon
558
Parker-Hannifin
PH
$133B
$1K ﹤0.01%
5
PTC icon
559
PTC
PTC
$16.5B
$1K ﹤0.01%
16
PVH icon
560
PVH
PVH
$3.76B
$1K ﹤0.01%
4
SCL icon
561
Stepan Co
SCL
$1.48B
$1K ﹤0.01%
26
SNN icon
562
Smith & Nephew
SNN
$12.6B
$1K ﹤0.01%
40
SPR
563
DELISTED
Spirit AeroSystems
SPR
$1K ﹤0.01%
15
SPXC icon
564
SPX Corp
SPXC
$10.6B
$1K ﹤0.01%
24
SRE icon
565
Sempra
SRE
$56.5B
$1K ﹤0.01%
16
STLD icon
566
Steel Dynamics
STLD
$37.3B
$1K ﹤0.01%
27
TER icon
567
Teradyne
TER
$64.9B
$1K ﹤0.01%
26
THC icon
568
Tenet Healthcare
THC
$21.5B
$1K ﹤0.01%
17
TNL icon
569
Travel + Leisure Co
TNL
$4.57B
$1K ﹤0.01%
16
TROW icon
570
T. Rowe Price
TROW
$23.8B
$1K ﹤0.01%
15
-7,507
-100% -$612K
TSN icon
571
Tyson Foods
TSN
$19.9B
$1K ﹤0.01%
13
TTE icon
572
TotalEnergies
TTE
$193B
$1K ﹤0.01%
12,669,515
-11,402,564
-47% -$1.14K
UGI icon
573
UGI
UGI
$7.53B
$1K ﹤0.01%
21
UTHR icon
574
United Therapeutics
UTHR
$21.5B
$1K ﹤0.01%
6
VECO icon
575
Veeco
VECO
$3.29B
$1K ﹤0.01%
17

Similar funds

Archford Capital Strategies's Q4 2014 Portfolio in Review

As of Q4 2014, Archford Capital Strategies held 821 positions worth $136M, up 8.1% from $126M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Archford Capital Strategies's Q4 2014 filing shows 42 new, 153 increased, 89 reduced and 40 closed positions. Its largest new stake was AstraZeneca: 3,994 shares worth $281K. The largest sale was CSX Corp, an estimated $809K.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Archford Capital Strategies's largest Q4 2014 buy was AstraZeneca: 3,994 shares worth $281K.
  • Archford Capital Strategies added most to Dover in Q4 2014, an estimated $857K increase.
  • Archford Capital Strategies's biggest Q4 2014 reduction was CSX Corp, cutting an estimated $809K.
  • Archford Capital Strategies fully exited General Dynamics in Q4 2014, selling an estimated $734K.
  • Archford Capital Strategies's ten largest holdings make up 31% of its $136M portfolio in Q4 2014.
  • Archford Capital Strategies opened 42 new positions and closed 40 in Q4 2014.
  • Archford Capital Strategies's portfolio value rose 8.1% quarter-over-quarter to $136M.

Based on Archford Capital Strategies's 13F filing for Q4 2014, filed 3 Feb 2015.